AAAAAA
Results:
1-7
|
Results: 7
Authors:
Panikashvili, D
Simeonidou, C
Ben-Shabat, S
Hanus, L
Breuer, A
Mechoulam, R
Shohami, E
Citation: D. Panikashvili et al., An endogenous cannabinoid (2-AG) is neuroprotective after brain injury, NATURE, 413(6855), 2001, pp. 527-531
Authors:
Hanus, L
Abu-Lafi, S
Fride, E
Breuer, A
Vogel, Z
Shalev, DE
Kustanovich, I
Mechoulam, R
Citation: L. Hanus et al., 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1receptor, P NAS US, 98(7), 2001, pp. 3662-3665
Authors:
Bisogno, T
Hanus, L
De Petrocellis, L
Tchilibon, S
Ponde, DE
Brandi, I
Moriello, AS
Davis, JB
Mechoulam, R
Di Marzo, V
Citation: T. Bisogno et al., Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide, BR J PHARM, 134(4), 2001, pp. 845-852
Authors:
Mechoulam, R
Hanus, L
Citation: R. Mechoulam et L. Hanus, A historical overview of chemical research on cannabinoids, CHEM PHYS L, 108(1-2), 2000, pp. 1-13
Authors:
Basile, AS
Hanus, L
Mendelson, WB
Citation: As. Basile et al., Characterization of the hypnotic properties of oleamide, NEUROREPORT, 10(5), 1999, pp. 947-951
Authors:
Hanus, L
Breuer, A
Tchilibon, S
Shiloah, S
Goldenberg, D
Horowitz, M
Pertwee, RG
Ross, RA
Mechoulam, R
Fride, E
Citation: L. Hanus et al., HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor, P NAS US, 96(25), 1999, pp. 14228-14233
Authors:
Mechoulam, R
Hanus, L
Fride, E
Citation: R. Mechoulam et al., Towards cannabinoid drugs - revisited, PROG MED CH, 35, 1998, pp. 199-243
Risultati:
1-7
|